Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$95.06 - $111.52 $8,365 - $9,813
88 Added 15.04%
673 $74,000
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $32,694 - $40,033
-283 Reduced 32.6%
585 $82,000
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $101,260 - $112,024
868 New
868 $103,000
Q1 2021

May 04, 2021

SELL
$108.84 - $128.23 $20,570 - $24,235
-189 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $1.2 Million - $1.31 Million
-11,440 Reduced 98.37%
189 $21,000
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $964,144 - $1.17 Million
-10,521 Reduced 47.5%
11,629 $1.27 Million
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $526,265 - $673,554
6,873 Added 44.99%
22,150 $2.03 Million
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $130,539 - $190,885
-2,078 Reduced 11.97%
15,277 $1.21 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $1.25 Million - $1.39 Million
-15,917 Reduced 47.84%
17,355 $1.5 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $1.69 Million - $1.83 Million
20,660 Added 163.81%
33,272 $2.77 Million
Q2 2019

Aug 08, 2019

BUY
$72.88 - $85.0 $316,299 - $368,900
4,340 Added 52.47%
12,612 $1.06 Million
Q1 2019

May 01, 2019

BUY
$66.22 - $80.06 $420,430 - $508,300
6,349 Added 330.16%
8,272 $659,000
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $1.08 Million - $1.23 Million
-16,524 Reduced 89.58%
1,923 $139,000
Q3 2018

Nov 08, 2018

BUY
$60.81 - $73.36 $418,920 - $505,377
6,889 Added 59.6%
18,447 $1.35 Million
Q2 2018

Aug 01, 2018

BUY
$57.57 - $63.54 $272,363 - $300,607
4,731 Added 69.3%
11,558 $702,000
Q1 2018

May 02, 2018

SELL
$56.27 - $63.62 $25,602 - $28,947
-455 Reduced 6.25%
6,827 $407,000
Q4 2017

Feb 06, 2018

SELL
$53.68 - $57.47 $27,323 - $29,252
-509 Reduced 6.53%
7,282 $414,000
Q3 2017

Nov 06, 2017

SELL
$48.06 - $53.64 $95,927 - $107,065
-1,996 Reduced 20.39%
7,791 $414,000
Q2 2017

Aug 15, 2017

BUY
N/A
9,787
9,787 $477,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.